期刊文献+

小儿血管瘤组织TRAIL蛋白与细胞增殖和凋亡检测 被引量:3

Detection of expression of TRAIL, cell proliferation and apoptosis in children′s skin hemangioma
下载PDF
导出
摘要 目的探讨小儿皮肤血管瘤各阶段肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达与细胞增殖和凋亡的关系。方法应用流式细胞术检测23例增生期、20例消退期血管瘤和15例正常皮肤组织中TRAIL蛋白的相对含量,细胞增殖指数(PI)和细胞凋亡率(AR)。结果增生期血管瘤、消退期血管瘤和正常皮肤组织中TRAIL蛋白的表达分别为1.26±0.56,1.74±0.68,1.00±0.23,PI分别为(40.98±12.02)%,(20.05±3.67)%,(15.64±4.01)%,AR分别为(11.96±4.02)%,(20.29±3.53)%,(6.61±1.29)%。3组间以上3指标两两比较,差异均有统计学意义。血管瘤组织中TRAIL蛋白的含量与AR呈正相关(r=0.36,P<0.05)。结论TRAIL蛋白诱导的凋亡可能参与了血管瘤由增生向消退的演变,细胞增殖和凋亡平衡关系的改变可能是血管瘤自行消退的重要原因之一。 Aim : To investigate the relationship between the expression of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL), cell proliferation and apoptosis in children's skin hemangioma. Methods:The level of TRAIL, the proliferation index (PI) and apoptosis rate (AR) were detected by flow cytometer (FCM) analysis in 23 case of hemangioma at proliferating phase, 20 cases of hemangioma at involuting phase, and 15 cases of normal skin. Results: In hemangioma at proliferating phase, hemangioma at involuting phase, and normal skin, the expressions of TRAIL were 1.26 ± 0.56, 1.74 ±0.68, and 1.00 ±0.23,PI was (40.98 ±2.02)% ,(20.05 ±3.67)% and (15.64 ±4.01)%, AR was (11.96 ± 4.02) %, ( 20.29 ± 3.53) % and ( 6.61 ± 1.29 ) %, respectively. There were significant differences among the 3 groups in the 3 parameters. The expression of TRAIL was positively correlated with AR ( r = 0.36, P 〈 0.05 ). Conclusion: TRAIL might be involved in the switch from uncontrolled growth to spontaneous involution of hemangioma, probably by inducing apoptosis. The equilibrium between cell proliferation and apoptosis might play a crucial role in the regression of hernangioma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第3期548-550,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 血管瘤 肿瘤坏死因子相关凋亡诱导配体 细胞增殖 细胞凋亡 hemangioma tumor necrosis factor-related apoptosis-inducing ligand cell proliferation apoptosis
  • 相关文献

参考文献1

二级参考文献55

  • 1Takeda K, Smyth MJ, Cretney E, et al. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 2002; 195:161-9. 被引量:1
  • 2Smyth M J, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon y-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193:661-70. 被引量:1
  • 3Takeda K, Smyth MJ, Cremey E, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-y-dependent suppression of subcutaneous tumor growth. Cell Immunol 2001; 214:194-200. 被引量:1
  • 4Frank S, Kohler U, Schackert G, Schackert HK. Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun 1999; 257:454-9. 被引量:1
  • 5Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.Science 1997; 277:818-21. 被引量:1
  • 6Jo M, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000; 6:564-7. 被引量:1
  • 7Zheng SJ, Wang P, Tsabary G, Chen YH. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J Clin Invest 2004; 113:58-64. 被引量:1
  • 8Lawrence D, Shahrokh Z, Marsters S, et al. Differential hepatocyte toxicity of recombinant Apo21/TRAIL versions. Nat Med 2001; 7:383-5. 被引量:1
  • 9Lin T, Gu J, Zhang L, et al. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcfiptase promoter elicits antitumor activity without toxic effects on primary human hepatocvtes. Cancer Res 2002:62:3620-5. 被引量:1
  • 10Yamashita Y, Shimada M, Tanaka S, et al. Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo21 gene therapy for hepatocellular carcinoma. Hum Gene Ther 2002; 13:275-86. 被引量:1

共引文献21

同被引文献49

  • 1何超,胡文献,胡晓彤,黄学锋.γ-干扰素加强TRAIL抑制人大肠癌细胞株作用的研究[J].中国病理生理杂志,2006,22(2):365-367. 被引量:2
  • 2秦兴军,张恩礁,王绪凯,孙长伏.细胞间黏附分子1和血管细胞黏附分子1在血管瘤组织中表达的意义[J].中国医科大学学报,2006,35(3):275-276. 被引量:3
  • 3Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity, 1995, 3 (6): 673-682. 被引量:1
  • 4Pippi RM, Marsters SA, RuppEert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family[J].J Biol Chem, 1996, 271 (22) : 12687-12690. 被引量:1
  • 5Mac FM. TRAIL-induced signaling and apoptosis[J].Toxicol Lett, 2003, 139 (2-3):89-97. 被引量:1
  • 6Almasan A, Ashenazi A. Apo2L/TRAIL:apoptosis signaling, biology and potential for cancer therapy[J].CytokineGrowthFaetorRev, 2003,14(3-4): 337-348. 被引量:1
  • 7Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy reeeptors[J].Science, 1997, 277 (5327) : 818-821. 被引量:1
  • 8Kassis R, Larrous F, Estaquier J, et al. Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation[J]. J Virol, 2004, 78 (12) : 6543-6555. 被引量:1
  • 9Thomas LR, Henson A, Reed JC, et al. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD[J].J Biol Chem, 2004, 279 (31): 32780-32785. 被引量:1
  • 10Yang X, Merchant MS, Romero ME, et al. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/ TR2 also contributes to TRAIL resistance in NB[J].Cancer Res, 2003, 63 (5): 1122-1129. 被引量:1

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部